clinical trial for retatrutide latest results trials phase approval: FDA status, results, and when it could be available Do not obsess over Retatrutide. – Phase III retatrutide study demonstrates – retatrutide dosing in clinical trials

[23] Establishing regular eating patterns helps stabilise blood glucose levels and prevents hunger-related headaches

This gives you six doses of 2.5 mg or three doses of 5 mg from a single vial

Clinical trials have documented substantial weight loss with these medicationstypically 15% of body weight with semaglutide 2.4 mg (STEP 1 trial) and approximately 21% with tirzepatide 15 mg (SURMOUNT-1 trial) at 72 weeks

Can be used daily, AM and PM

I spoke to my colleague Dani Blum on the Well team to find out how they work and who should and shouldnt take them

However, the best treatment for you will depend on your individual circumstances